ArticleMolecular and clinical oncology2025

Clinical significance of cyclin-dependent kinase inhibitor 3 in hepatocellular carcinoma.

Xing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.